Stock listing

TSXV:NRX Nurexone Biologic Inc Stock

Home listing (TSXV) of Nurexone Biologic Inc

Follow Nurexone Biologic Inc into a list and get an email when it puts out news.

Share price · TSXV:NRX

$0.60 CAD +0.02 (+3.4%)

Close on Oct 15, 2026

Nurexone Biologic Inc logo
Ticker
TSXV:NRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TSXV
Currency
CAD

What changed lately

Latest news

NurExone Advances Optic Nerve Injury Program Toward Larger-Animal Study, Following Positive Preclinical Results

Oct 9, 2026

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Sep 18, 2026

NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update

Sep 16, 2026

NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications

Sep 14, 2026

NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results

Aug 31, 2026

NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Aug 28, 2026

NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy

Aug 21, 2026

NurExone Announces Closing of C$1,066,078 Private Placement

Aug 21, 2026

NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model

Aug 14, 2026

NurExone Announces Binding MOU with Made Scientific for U.S. GMP Manufacturing and Commercial Supply Partnership

Aug 12, 2026

All Nurexone Biologic Inc news

Financings

  • Private placement of units

    Aug 31, 2026

    Closed: C$1.07M in the latest tranche · C$0.55 a unit · 1 warrant at C$0.69 for 36 months · free to trade Dec 21, 2026

    Insiders: No insiders participated in this Offering

    Use of proceeds: General working capital

    Closed Aug 21, 2026 · Closed Aug 31, 2026

Read by 6ix AI from the company's releases

Decks

Nurexone Biologic Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
34 in the last 12 months · 90 in all · newest Oct 9, 2026 · oldest 2022
Decks
8 decks · latest September 2026

Where Nurexone Biologic Inc is listed

ListingExchangeCountryCurrency
TSXV:NRX · Home listing · This pageTSXVCanadaCAD
gettex:J90gettexGermanyEUR
Tradegate:J90TradegateGermanyEUR
Lang & Schwarz:A3DNSULang & SchwarzGermanyEUR
LS Exchange:A3DNSULS ExchangeGermanyEUR
OTC:NRXBFOTCUnited StatesUSD
Cboe Canada:NRXCboe CanadaCanadaCAD
Frankfurt:J90FrankfurtGermanyEUR
Stuttgart:J90StuttgartGermanyEUR
Dusseldorf:J90DusseldorfGermanyEUR
Hamburg:J90HamburgGermanyEUR
Munich:J90MunichGermanyEUR

Log in to ask 6ix AI your own questions about Nurexone Biologic Inc.